New York Times

Child Experts Fail to Reveal Full Drug Pay
By Gardiner Harris and Benedict Carey

June 8, 2008

A world-renowned Harvard child psychiatrist whose work has helped fuel
an explosion in the use of powerful antipsychotic medicines in
children earned at least $1.6 million in consulting fees from drug
makers from 2000 to 2007 but for years did not report much of this
income to university officials, according to information given
Congressional investigators.

Senator Charles E. Grassley pushed three experts in child psychiatry
at Harvard to expose their income from consulting fees.

Dr. Joseph Biederman belatedly reported at least $1.6 million in
consulting fees.